Consensus Bausch Health Companies Inc.

Equities

BHC

CA0717341071

Market Closed - Nyse Other stock markets 04:00:01 2024-04-24 pm EDT			5-day change	1st Jan Change
8.56 ^USD	+0.35%		-1.15%	+6.73%

Apr. 23	Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says	MT
Apr. 23	RBC Previews Bausch Health's Q1, Trims Target to US$11	MT

Evolution of the average Target Price on Bausch Health Companies Inc.

Price target over the last 5 years

History of analyst recommendation changes

7170488d9e657cd22c9702d393a63a4.PjsVOF_wmeIjQ7IrvPJkHt0KkA6wmeFtz1kyEvGkC78.CVVzXSm2y6xbCNFo6aQuarU882Heyo4GhjBVRYTAW-9vbFBcaYTjjBIJxQ~f968ad02ad61d9250b73a80d4e2cd55a

Analyst Recommendations on Bausch Health Companies Inc.

RBC Trims Price Target on Bausch Health to $11 From $12, Keeps Sector Perform Rating	Apr. 23	MT
Bausch Health's Issuer Credit Rating Upgraded by S&P	Apr. 19	MT
Trump eyes $43 million haul from biggest fundraiser yet	Apr. 06	RE
RBC Ups PT on Bausch Health Companies to $12 From $9 Reflecting Upcoming Appellate Court Decisions & Potential BLCO Distribution, Maintains Sector Perform Rating	Apr. 05	MT
RBC Lifts Price Target on Bausch Health to $9 From $8, Keeps Sector Perform Rating	Feb. 23	MT
North American Morning Briefing : Mood Lifted on Hopes Rate-Hike Cycle Has Peaked	Nov. 02	DJ
RBC Cuts Price Target on Bausch Health to $8 From $9 Ahead of Q3 Report, Keeps Sector Perform Rating	23-10-23	MT
Fitch Affirms Bausch Health, Bausch Health America's Ratings; Bausch + Lomb's Rating Maintained	23-10-04	MT
Jefferies Upgrades Bausch Health to Buy From Hold, Adjusts Price Target to $16 From $9	23-09-20	MT
Moody's Rates Bausch + Lomb's New Secured Debt Instruments	23-09-12	MT
RBC Boosts Price Target on Bausch Health to $9 From $8 Ahead of Q2 Report, Maintains Sector Perform Rating	23-07-24	MT
TD Cowen Downgrades Bausch Health to Market Perform From Outperform, Adjusts Price Target to $12 From $35	23-06-16	MT
Jefferies Adjusts Price Target on Bausch Health to $9.50 From $7, Maintains Hold Rating	23-05-22	MT
RBC Cuts Price Target on Bausch Health to $8 From $9, Notes Concerns for Ability to Distribute Bausch + Lomb Shares, Keeps Sector Perform Rating	23-05-05	MT
Factbox-US government to impose inflation penalties on 27 drugs	23-03-15	RE
Bausch Health Price Target Raised to US$10 (From US$8), Market Perform Rating Maintained After "Solid Q4" and 2023 Guide	23-02-24	MT
RBC Lifts Price Target on Bausch Health to $9 From $8, Maintains Sector Perform Rating	23-02-24	MT
Fitch Lowers Bausch Health to RD; Upgrades to CCC Post Distressed Exchange; Also Downgrades Bausch + Lomb	22-10-07	MT
Fitch Downgrades Bausch Health to 'RD'; Upgrades to 'CCC' Post Distressed Exchange	22-10-07	AQ
Fitch Downgrades Bausch + Lomb's IDR to 'B-'; Evolving Rating Watch Pre and Post Downgrade	22-10-07	AQ
S&P Upgrades Bausch Health, Affirms Rating on Bausch + Lomb	22-10-05	MT
Piper Sandler Adjusts Bausch Health Cos.' Price Target to $6 from $7, Reiterates Neutral Rating	22-09-09	MT
Fitch Downgrades Bausch Health, Bausch Health Americas; Rating Watch Negative Removed	22-09-01	MT
RBC Capital Adjusts Bausch Health Price Target to $8 From $4.50, Maintains Sector Perform Rating	22-09-01	MT
Fitch Downgrades Bausch Health Co's IDR to 'C' on Proposed Distressed Debt Exchange	22-09-01	AQ

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

8.56 USD

Average target price

10.07 USD

Spread / Average Target

+17.66%

High Price Target

16 USD

Spread / Highest target

+86.92%

Low Price Target

7 USD

Spread / Lowest Target

-18.22%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bausch Health Companies Inc.

RBC Capital Markets
Jefferies & Co.
TD Cowen
Piper Sandler
BMO Capital
Stifel Nicolaus
Truist Securities
JPMorgan Chase
Barclays
Spin-Off Research
BofA Securities
HC Wainwright
J.P. Morgan Chase

Ratings for Bausch Health Companies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar